Kristina E N Clark - Concepedia

Author

Kristina E N Clark

Also Known As

C Florissi, Clark, KEN, K Clark, K E N Clark, K. CLARK, K. Clark, K. E. N. Clark, K.E.N. Clark, Kristina Clark, Kristina E Clark

Publications

561

Citations

H-Index

Concepts

All Affiliations

University College London The Royal Free Hospital Royal Free London NHS Foundation Trust

About

Kristina E N Clark is an author at University College London specializing in medicine, immunology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	174
2	Public Health	1	1	20
3	Social Sciences	1	1	18
4	Allergy	1	1	52
5	Epidemiology	1	1	20

Kristina E N Clark

Publications

444

Citations

H-Index

Page 1

	Year	Citations
THE VALUE OF POSTTRANSPLANT MONITORING OF INTERLEUKIN (IL)-2, IL-3, IL-4, IL-6, IL-8, AND SOLUBLE CD23 IN THE PLASMA OF RENAL ALLOGRAFT RECIPIENTS Necil Kütükçüler, Kristina E N Clark, Keith Rigg, Transplantation Transplantation MedicineImmunologyPathologyImmunotherapySoluble Cd23	1995	52
Variation in C - reactive protein response according to host and mycobacterial characteristics in active tuberculosis James Brown, Kristina E N Clark, Colette Smith, BMC Infectious Diseases	2016	47
Combining nano-physical and computational investigations to understand the nature of &ldquo;aging&rdquo; in dermal collagen Tarek Ahmed, Anthony Nash, Kristina E N Clark, International Journal of Nanomedicine	2017	40
Molecular basis for clinical diversity between autoantibody subsets in diffuse cutaneous systemic sclerosis Kristina E N Clark, Corrado Campochiaro, Eszter Csomor, Annals of the Rheumatic Diseases	2021	32
Multiplex cytokine analysis of dermal interstitial blister fluid defines local disease mechanisms in systemic sclerosis Kristina E N Clark, Henry Lopez, Bahja Ahmed Abdi, Arthritis Research & Therapy InflammationCytokineAutoimmune DiseaseImmune RegulationImmunology	2015	29
Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes Kristina E N Clark, Corrado Campochiaro, Lauren Host, Scientific Reports	2022	25
The pan-PPAR agonist lanifibranor reduces development of lung fibrosis and attenuates cardiorespiratory manifestations in a transgenic mouse model of systemic sclerosis Emma Derrett‐Smith, Kristina E N Clark, Shiwen Xu, Arthritis Research & Therapy	2021	24
Pharmacokinetics and Safety of Single, Multiple, and Loading Doses of Fusidic Acid in Healthy Subjects James Still, Kristina E N Clark, Thorsten P. Degenhardt, Clinical Infectious Diseases Plasma ExposureFusidic AcidAntibioticsHealthy SubjectsAntimicrobial Susceptibility	2011	22
Single-cell analysis reveals key differences between early-stage and late-stage systemic sclerosis skin across autoantibody subgroups Kristina E N Clark, Shiwen Xu, Moustafa Attah, Annals of the Rheumatic Diseases	2023	21
Assessment of the Hemophagocytic Lymphohistiocytosis HScore in Patients With Coronavirus Disease 2019 Kristina E N Clark, William D Nevin, Tabitha Mahungu, Clinical Infectious Diseases Viral DiagnosticsPrognosisImmunologyMolecular Inflammatory ResponseCovid-19 Epidemiology	2020	20

Page 1